Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Melinda Brown | Director | 2025-03-26 | 1,839 | $4.75 | $8.74kBuy |
Kevin Buehler | Director | 2025-03-26 | 4,523 | $4.67 | $21.12kBuy |
Geno J. Germano | Director | 2025-03-25 | 3,250 | $5.30 | $17.23kBuy |
Michael Amoroso | President and CEO | 2025-03-24 | 964 | $5.56 | $5.36kSell |
J. Jefferson Smith | Chief Research Officer | 2025-03-04 | 154 | $4.91 | $756.14Sell |
Dario Scimeca | General Counsel and Secretary | 2025-03-04 | 272 | $4.91 | $1.34kSell |
Dario Scimeca | General Counsel and Secretary | 2025-01-22 | 8,928 | $4.79 | $42.77kSell |
J. Jefferson Smith | Chief Research Officer | 2025-01-22 | 10,287 | $4.79 | $49.27kSell |
Michael Amoroso | President and CEO | 2025-01-21 | 36,838 | $4.67 | $172.03kSell |
Geno J. Germano | Director | 2024-12-30 | 3,605 | $4.49 | $16.19kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Pharma Ag Novartis | 111.90% | 12,407,440 | $60.80M | Insider |
Venbio Global Strategic Fund LP | 38.47% | 4,265,141 | $20.90M | Insider |
Derek Jantz | 36.57% | 4,055,174 | $19.87M | Insider |
Fmr LLC | 33.71% | 3,738,248 | $18.32M | Insider |
Matthew R. Kane | 18.26% | 2,024,438 | $9.92M | Insider |
Lynx1 Capital Management LP | 6.91% | 766,051 | $3.75M | Institution |
Aquilo Capital Management LLC | 6.55% | 726,149 | $3.56M | Institution |
Tang Capital Management LLC | 6.07% | 673,332 | $3.30M | Institution |
Vanguard Group Inc | 2.53% | 281,083 | $1.38M | Institution |
Acadian Asset Management LLC | 2.24% | 248,620 | $1.22M | Institution |